Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04495907 · ClinicalTrials.gov registry record
COVID-19 Progression in End-Stage Kidney Disease
A clinical trial, sponsored by Davita Clinical Research.
- Completed
- Registry status
- 412
- Enrollment target
NCT04495907: Completed study, sponsored by Davita Clinical Research.
NCT04495907 is a clinical trial that has completed, run by Davita Clinical Research. The registered enrollment target is 412 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04495907 has completed, sponsored by Davita Clinical Research.
- COMPLETED
- Registry status
- 412 participants
- Enrollment target
Study Summary
The purpose of this study is to collect genomic and clinical data among a cohort of hemodialysis patients and analyze the association between genetic markers and the development and severity of illness in response to SARS-CoV-2.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 412 participants |
| Start Date | 2020-08-06 |
| Est. Completion | 2021-08-31 |
What the finished NCT04495907 record still lists
NCT04495907 is an observational study that tracks outcomes without assigning an intervention. The registered 412 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04495907 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04495907 about?
NCT04495907 is a clinical study titled "COVID-19 Progression in End-Stage Kidney Disease". The purpose of this study is to collect genomic and clinical data among a cohort of hemodialysis patients and analyze the association between genetic markers and the development and severity of illness in response to SARS-CoV-2.
What is the current status of trial NCT04495907?
This trial is currently completed. The enrollment target is 412 participants. The study started on 2020-08-06. Estimated completion is 2021-08-31.
Who is sponsoring clinical trial NCT04495907?
This trial is sponsored by Davita Clinical Research, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05993689 · 412 participants · NA
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
- NCT06699212 · 412 participants · Phase 3
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- NCT03592472 · 413 participants · Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- NCT06697197 · 413 participants · Phase 1
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI